Cite
HARVARD Citation
Kim, H. et al. (2016). The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress. BMC cancer. 16 (1), pp. 1-7. [Online].